TY - JOUR
T1 - Additive manufacturing of pharmaceuticals for precision medicine applications
T2 - A review of the promises and perils in implementation
AU - Trivedi, Megha
AU - Jee, Joann
AU - Silva, Suzanila
AU - Blomgren, Carmel
AU - Pontinha, Vasco M.
AU - Dixon, Dave L.
AU - Van Tassel, Benjamin
AU - Bortner, Michael J.
AU - Williams, Christopher
AU - Gilmer, Eric
AU - Haring, Alexander P.
AU - Halper, Justin
AU - Johnson, Blake N.
AU - Kong, Zhenyu
AU - Halquist, Matthew S.
AU - Rocheleau, Paul F.
AU - Long, Timothy E.
AU - Roper, Thomas
AU - Wijesinghe, Dayanjan S.
N1 - Publisher Copyright:
© 2018 Elsevier B.V.
PY - 2018/10
Y1 - 2018/10
N2 - Precision medicine is an emerging field in healthcare that seeks to tailor preventive and therapeutic strategies to the unique physiology, biochemistry, lifestyles, and genetics of individual patients. There are several technologies that are key to the successful delivery of precision medicine including pharmacogenomics, pharmacometabolomics, improved point-of-care testing, and therapeutically-tailored medications. The inclusion of additive manufacturing (AM) technology, more commonly known as 3D printing, in the manufacture of oral dosage forms such as tablets, provides an avenue for the implementation of precision medicine in current healthcare practice via the prescription of specific dosage forms and drug combinations tailored to individual needs. Widespread commercialization of AM of pharmaceuticals has the potential to disrupt the supply chain used by the healthcare industry worldwide with the cost-saving potential of minimizing waste related to unused, expired medications. Despite the potential of this technology, many clinical and regulatory challenges will need to be addressed prior to large-scale implementation of AM fabricated therapeutics for precision medicine applications. This review investigates both the potential and the challenges of delivering AM fabricated medications for therapeutic use in precision medicine applications.
AB - Precision medicine is an emerging field in healthcare that seeks to tailor preventive and therapeutic strategies to the unique physiology, biochemistry, lifestyles, and genetics of individual patients. There are several technologies that are key to the successful delivery of precision medicine including pharmacogenomics, pharmacometabolomics, improved point-of-care testing, and therapeutically-tailored medications. The inclusion of additive manufacturing (AM) technology, more commonly known as 3D printing, in the manufacture of oral dosage forms such as tablets, provides an avenue for the implementation of precision medicine in current healthcare practice via the prescription of specific dosage forms and drug combinations tailored to individual needs. Widespread commercialization of AM of pharmaceuticals has the potential to disrupt the supply chain used by the healthcare industry worldwide with the cost-saving potential of minimizing waste related to unused, expired medications. Despite the potential of this technology, many clinical and regulatory challenges will need to be addressed prior to large-scale implementation of AM fabricated therapeutics for precision medicine applications. This review investigates both the potential and the challenges of delivering AM fabricated medications for therapeutic use in precision medicine applications.
UR - http://www.scopus.com/inward/record.url?scp=85052479458&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85052479458&partnerID=8YFLogxK
U2 - 10.1016/j.addma.2018.07.004
DO - 10.1016/j.addma.2018.07.004
M3 - Review article
AN - SCOPUS:85052479458
SN - 2214-8604
VL - 23
SP - 319
EP - 328
JO - Additive Manufacturing
JF - Additive Manufacturing
ER -